Survival of HIV-infected patients in the intensive care unit in the era of highly active antiretroviral therapy

Thorax

Volumn 62, Issue 11, 2007, Pages 964-968

  Dickson, S J ^b   Batson, S ^a   Copas, A J ^c   Edwards, S G ^a   Singer, M ^a   Miller, R F ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; HEMOGLOBIN;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INTENSIVE CARE UNIT; LACTIC ACIDOSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY TRACT DISEASE; SURVIVAL;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INTENSIVE CARE; MALE; PNEUMONIA, PNEUMOCYSTIS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 35649022138     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2006.072256     Document Type: Article

References (25)

1. Health Protection Agency. A complex picture - HIV and other sexually transmitted infections in the United Kingdom: 2006. London: The UK Collaborative Group for HIV and STI Surveillance, Health Protection Agency, http://www.hpa.org.uk/publications/2006/hiv_sti_2006/contents.htm (accessed 5 March 2007).
2. Morris A, Creasman J, Turner J, et al. Intensive care of human immunodeficiency virus-infected patients during the era of highly active antiretroviral therapy. Am J Respir Crit Care Med 2002;166:262-7.
3. Wachter RM, Luce JM, Turner J, et al. Intensive care of patients with the acquired immunodeficiency syndrome. Outcome and changing patterns of utilization. Am Rev Respir Dis 1986;134:891-6.
4. Schein RM, Fischl MA, Pitchenik A, et al. ICU survival of patients with the acquired immunodeficiency syndrome. Crit Care Med 1986;14:1026-7.
5. Smith RL, Levine SM, Lewis ML. Prognosis of patients with AIDS requiring intensive care. Chest 1989;96:857-61.
6. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection: HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-60.
7. Valdez H, Chowdhry TK, Asaad R, et al. Changing spectrum of mortality due to human immunodeficiency virus: analysis of 260 deaths during 1995-1999. Clin Infect Dis 2001;32:1487-93.
8. Mocroft A, Ledergerber B, Katlama C, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 2003;362:22-9.
9. Morris A, Wachter RM, Luce J, et al. Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia. AIDS 2003;17:73-80.
10. Narasimhan M, Posner AJ, DePalo VA, et al. Intensive care in patients with HIV infection in the era of highly active antiretroviral therapy. Chest 2004;125:1800-4.
11. Vincent B, Timsit JF, Auburtin M, et al. Characteristics and outcomes of HIV-infected patients in the ICU. Impact of the highly active antiretroviral treatment era. Intensive Care Med 2004;30:859-66.
12. Casalino E, Wolff M, Ravaud P, et al. Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit. AIDS 2004;18:1429-33.
13. Khouli H, Afrasiabi A, Shibli M, et al. Outcome of critically ill human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. J Intensive Care Med 2005;20:327-33.
14. Palacios R, Hildalgo A, Reina C, et al. Effect of antiretroviral therapy on admissions of HIV-infected patients to an intensive care unit. HIV Med 2006;7:193-6.
15. Miller RF, Allen E, Copas A, et al. Improved survival for HIV infected patients with severe Pneumocystis jirovecii is independent of highly active antiretroviral therapy. Thorax 2006;61:716-21.
16. Dean G, Williams DI, Churchill DR, et al. Transient clinical deterioration in HIV patients with Pneumocystis carinii pneumonia after starting highly active antiretroviral therapy: another case of immune restoration inflammatory syndrome. Am J Respir Crit Care Med 2002;165:1671-2.
17. Wislez M, Bergot, Antoine M, et al. Acute respiratory failure following HAART introduction in patients treated for Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 2002;164:847-5.
18. Masur H. Management of patients with HIV in the intensive care unit. Proc Am Thorac Soc 2006;3:96-102.
19. Huang L, Quartain A, Jones D, et al. Intensive care of patients with HIV infection. N Engl J Med 2006;355:173-81.
20. Gill JK, Greene L, Miller R, et al. ICU admission in patients infected with the human immunodeficiency virus - a multicentre survey. Anaesthesia 1999;54:727-32.
21. Nickas G, Wachter RM. Outcomes of intensive care for patients with human immunodeficiency virus infection. Arch Intern Med 2000;160:541-7.
22. Afessa B, Green B. Clinical course, prognostic factors, and outcome prediction for HIV patients in the ICU. The PIP (Pulmonary complications, ICU support, and prognostic factors in hospitalized patients with HIV) study. Chest 2000;118:138-45.
23. Harrison DA, Brady AR, Rowan K. Case mix, outcome and length of stay for admissions to adult, general critical care units in England, Wales and Northern Ireland: the intensive care National Audit & Research Centre Case Mix Programme database. Crit Care 2004;8:R99-111.
24. British HIV Association (BHIVA). http://www.bhiva-clinical-audit. org.uk (accessed 28 February 2007).
25. Williams TA, Dobb GJ, Finn JC, et al. Long-term survival from intensive care: a review. Intensive Care Med 2005;31:1306-15.